Avalon Trust CO Danaher Corp Transaction History

Avalon Trust CO

$1.54 Trillion
Q3 2025

A detailed history of Avalon Trust CO transactions in Danaher Corp stock. As of the latest transaction made, Avalon Trust CO holds 78,807 shares of DHR stock, worth $17.4 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

78,807

Previous 74,960 5.13%

Holding current value

$17.4 Million

Previous $14.8 Billion 5.52%

% of portfolio

1.01%

Previous 1.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$181.46 - $212.2 $698,076 - $816,333	3,847 Added 5.13%	78,807 $15.6 Billion
Q2 2025 Aug 08, 2025	BUY	$174.64 - $205.16 $1.32 Million - $1.55 Million	7,554 Added 11.21%	74,960 $14.8 Billion
Q1 2025 May 09, 2025	SELL	$201.62 - $250.59 $44,356 - $55,129	-220 Reduced 0.33%	67,406 $13.8 Billion
Q4 2024 Feb 10, 2025	SELL	$226.16 - $274.52 $9,951 - $12,078	-44 Reduced 0.07%	67,626 $15.5 Billion
Q3 2024 Nov 13, 2024	SELL	$239.25 - $280.76 $331,361 - $388,852	-1,385 Reduced 2.01%	67,670 $18.8 Billion

Q2 2024 Aug 12, 2024	SELL	$235.51 - $267.98 $52,989 - $60,295	-225 Reduced 0.32%	69,055 $17.3 Billion
Q1 2024 May 07, 2024	BUY	$224.58 - $256.19 $1.22 Million - $1.39 Million	5,420 Added 8.49%	69,280 $17.3 Billion
Q4 2023 Feb 06, 2024	SELL	$185.1 - $233.13 $96,252 - $121,227	-520 Reduced 0.81%	63,860 $14.8 Billion
Q3 2023 Nov 13, 2023	SELL	$233.08 - $265.59 $124,697 - $142,090	-535 Reduced 0.82%	64,380 $16 Billion
Q2 2023 Aug 09, 2023	SELL	$224.99 - $256.14 $10,124 - $11,526	-45 Reduced 0.07%	64,915 $15.6 Billion
Q1 2023 May 11, 2023	BUY	$239.75 - $277.0 $15.6 Million - $18 Million	64,960 New	64,960 $16.4 Billion

Others Institutions Holding DHR

# of Institutions

2,484

Shares Held

571M

Call Options Held

5.44M

Put Options Held

3.44M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $160B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Trust CO with notifications on news.

Account